3 results
Approved WMOCompleted
The objective is to assess whether analysis of the initial coronary CTA datasets using AR technology would affect the PCI treatment strategy and its immediate results as compared to traditional PCI under angiographic guidance alone.
Approved WMORecruiting
The aim of ImmunoSep is to study if personalized immunotherapy targeting either fulminant hyper-inflammation or immunoparalysis is able to improve sepsis outcomes.
Approved WMOWill not start
The main objective of this trial is to investigate the efficacy of inhaled molgramostim compared to placebo.